| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |